Arvaya Healthcare Completes Major Acquisitions, Reports ₹1.47 Crore Consolidated Profit for Q4 FY26

Arvaya Healthcare Limited, previously known as Bijoy Hans Limited, has announced its financial results for the fourth quarter and full year ended March 31, 2026. The company reported a consolidated profit after tax of ₹1.47 crore for Q4 FY26. This comes alongside significant strategic developments including the acquisition of three healthcare entities and a corporate name change.

Reader Takeaway: Consolidated profit driven by acquisitions, while standalone business faces losses. Litigation remains a concern.

What Just Happened

Arvaya Healthcare Limited reported a consolidated profit of ₹1.47 crore for the fourth quarter of the fiscal year 2025-2026. The company also posted a consolidated profit of ₹0.90 crore for the full fiscal year. In contrast, the company's standalone operations registered a loss of ₹0.63 crore in Q4 FY26. Key strategic moves include the acquisition of 100% equity in Health Secure Hospitals Private Limited, Arvaya Health and Wellness Private Limited, and Tec-Pool Solutions Private Limited for a total consideration of ₹60.65 crore. The company has also officially changed its name from Bijoy Hans Limited to Arvaya Healthcare Limited, effective May 11, 2026, to reflect its new focus. The board has approved an increase in authorized share capital from ₹60 crore to ₹200 crore.

Why This Matters

The results highlight a significant transformation for the company, with its future growth heavily reliant on the newly acquired healthcare subsidiaries. The consolidated profit indicates that these acquisitions are already contributing to the group's bottom line, offsetting the losses from standalone operations. The name change and increased authorized capital signal a strategic pivot towards the healthcare services sector, suggesting potential for further expansion and investment.

The Backstory

Prior to these developments, the company operated under the name Bijoy Hans Limited. The recent acquisitions mark a definitive shift in its business model, moving from its previous operations into the healthcare domain. The acquired entities were consolidated into the company's financial statements from March 4, 2026, meaning the FY2026 results only capture a very short period of their operations.

What Changes Now

With the integration of three new healthcare businesses, Arvaya Healthcare is poised to operate as a diversified healthcare provider. Investors will now look towards the successful integration and operational synergy of these subsidiaries. The company's financial reporting will increasingly reflect the performance of its healthcare segment. The increase in authorized capital may pave the way for future fundraising activities to support growth.

Risks to Watch

Despite the positive consolidated figures, the standalone business continues to report losses, indicating a need for operational improvements. The company also faces contingent liabilities of approximately ₹3.72 crore related to ongoing litigation claims from medical consultants. While management expresses confidence in a favorable outcome, this remains a potential risk.

Peer Comparison

(No direct peer comparison data available in the provided filing.)

Context Metrics

• Consolidated Profit (Q4 FY26): ₹1.47 crore
• Consolidated Profit (FY26): ₹0.90 crore
• Standalone Loss (Q4 FY26): ₹0.63 crore
• Total Acquisition Cost: ₹60.65 crore
• Basic EPS (Consolidated, Q4 FY26): 0.26 INR

What to Track Next

Investors should closely monitor the quarterly financial reports to assess the sustained profitability of the consolidated entity, the performance and integration of the acquired subsidiaries, and any developments in the ongoing litigation. The company's ability to successfully manage its diversified operations will be key.